With shrinking earnings and below market growth rates, it's ...
With shrinking earnings and below market growth rates, it's hard to justify the high P/E ratio. Absent swift medium-term improvements, shares might drop and with it the P/E ratio. Current soaring prices may be risky, posing potential threats to investors.
Risks To Shareholder Returns Are Elevated At These Prices For BrightGene Bio-Medical Technology Co., Ltd. (SHSE:688166)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment